HIGHLIGHTS
- What: Managing diabetes during cancer treatment is a crucial aspect often overshadowed by the primary focus on cancer therapies.
- Who: Shahad Sabaawi Ibrahim from the Vegetative Anatomy, Institute of Anatomy, Faculty of Medicine, LMU Munich, Pettenkoferstr11, D‑, Munich, Germany have published the article: The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer, in the Journal: (JOURNAL)
- How: This review presents the triangle relationship of obesity DM as well as cancer development and elucidates the treatment of overweight-associated T2DM with semaglutide focusing on the question of whether . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.